LATEST NEWS

LIfT demonstrates how IMANs rapidly infiltrate tumours and recruit in other immune cells to destroy solid tumours together

LIfT’s CEO Alex Blyth detailed how Immuno-Modulatory Alpha Neutrophils (IMANs) outperform traditional neutrophils by rapidly infiltrating...

Dr. Bo Rode Hansen explains why he joined LIfT as a Non-Executive Director

We recently caught up with Dr. Bo Rode Hansen, a Non-Executive Director at LIfT, to find out what motivated him to join LIfT and why he...

LIfT’s CEO challenges out dated thinking that therapies focused on T-Cells alone are enough to achieve complete remission in most solid tumours

During a presentation at the Biotech Showcase, our CEO, Alex Blyth challenged the current view that T-cells can do it all, highlighting...